Skip to content

Perineal Consequences of Twin Pregnancies According to Mode of Delivery

Perineal Consequences of Twin Pregnancies According to Mode of Delivery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02059746
Acronym
JUMODA-CP
Enrollment
3039
Registered
2014-02-11
Start date
2014-02-28
Completion date
2016-03-01
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, Multiple

Keywords

cesarean section, vaginal birth, twins, urinary incontinence, sexuality, quality of life

Brief summary

This is an ancillary study to the JUMODA (National Prospective and Comparative Study on the Mode of Delivery of Twins) study: please see NCT01987063. The main objective of this study is to investigate the role of the mode of delivery (vaginal versus cesarean) as a risk factor for the occurrence of urinary incontinence at 3 months post-delivery in primiparous women delivering twins after 34 weeks of pregnancy.

Detailed description

The secondary objectives of this study are to compare the following elements between primiparous mothers giving birth to twins vaginally versus by caesarean section after 34 weeks of pregnancy (comparisons will be made at 3 months ant at 12 months post-partum): A. Diagnosis, type and severity of urinary incontinence via the ICIQ-UI questionnaire B. Urinary, anorectal and perineal symptoms via the PFDI-20 questionnaire C. Quality of life related to urinary, anorectal and pelvic floor symptoms via the PFIQ-7 questionnaire D. Sexuality via the PISQ-12 questionnaire E. General quality of life via the SF-12 questionnaire

Interventions

OTHERQuestionnaires sent by mail

The questionnaires necessary for the study are mailed to patients at 3 and 12 months post-partum.

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 12 months of follow-up following delivery * The patient was included in the JUMODA study * Primiparous * Birth of 2 live children after 34 weeks of pregnancy

Exclusion criteria

* Adult patient under guardianship * Patient under judicial protection * It proves impossible to correctly inform the patient * Birth occurring before 34 weeks of pregnancy * Birth not resulting in 2 living children

Design outcomes

Primary

MeasureTime frameDescription
Presence/absence of urinary incontinence3 months post-partumDefined by a response of 1 to 5 on the first question of the ICIQ-UI questionnaire.

Secondary

MeasureTime frameDescription
The PFDI-20 questionnaire3 months post-partum
The ICIQ-UI questionnaire3 months post-partumICIQ-Urinary Incontinence Form
The PFIQ-7 questionnaire3 months post-partum
The PISQ-12 questionnaire3 months post-partum
The SF-12 questionnaire3 months post-partum

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026